EM2204C "Aging and the Kidney: Lessons for Health?" (IM-GR040122)

Purpose and Overview

This lecture provides an overview of aging research, defines how normal aging unfolds in the human kidney, examines how kidney disease modifies many other age-associated diseases, and explores how kidney health may emerge as an important testing ground for interventions that target aging

Target Audience

 

UT Southwestern faculty, fellows, residents and medical students, community physicians, nurse clinicians, physician assistants and nurses.

 

Learning Objectives

At the conclusion of this activity, the participant should be able to:

  • Identify ways in which kidney health (or disease) modulates age-associated medical conditions
  • Describe features of normal aging in the kidney and distinguish aging from chronic kidney disease
  • LDiscuss emerging interventions that target human aging and CKD

 

Course summary
Available credit: 
  • 1.00 AMA
  • 1.00 Attendance
Course opens: 
04/04/2022
Course expires: 
05/06/2022
Cost:
$0.00
Rating: 
0

Photo: Samir M. Parikh, M.D.Samir M. Parikh, M.D.
Professor of Internal Medicine
Chief, Division of Nephrology

Dr. Parikh was born and raised in New Jersey. He attended Harvard where he graduated magna cum laude with a degree in chemistry before matriculating at Vanderbilt for medical school. Among several honors, he received the Founder’s Medal for highest academic standing in his graduating class. Dr. Parikh completed internship, residency, and nephrology fellowship at Beth Israel Deaconess Medical Center and Harvard Medical School. He attained the rank of Professor of Medicine at Harvard before moving to Dallas.

Dr. Parikh’s research is focused on mechanisms of resilience to acute physiological stressors. His work has identified major components of the host vascular response to severe infections, including the role of the endothelial tyrosine kinase Tie2. More recent studies have focused on the response of metabolically active cells and tissues to noxious insults, where his group has defined novel actions of the mitochondrial biogenesis factor PGC1alpha and the central metabolic cofactor NAD+. The studies on NAD+ homeostasis have translated to ongoing clinical trials in acute kidney injury (AKI), a common yet orphan stress-induced syndrome. Work from his team has been published in Nature, Nature Medicine, JCI, Science Translational Medicine, PNAS, and other high-impact journals. The group is now applying these insights to study renal development, links between AKI and chronic kidney disease, and more general questions of aging.

Available Credit

  • 1.00 AMA
  • 1.00 Attendance

Price

Cost:
$0.00
Please login or create an account to take this course.

Required Hardware/software

Activities should be run with recent versions of common browsers, including Internet Explorer, Firefox and Google Chrome